Jump Financial LLC grew its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 186.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 29,566 shares of the company's stock after acquiring an additional 19,247 shares during the period. Jump Financial LLC owned about 0.05% of Molina Healthcare worth $9,739,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the business. SVB Wealth LLC purchased a new position in shares of Molina Healthcare in the 1st quarter valued at $109,000. Smartleaf Asset Management LLC increased its stake in Molina Healthcare by 52.4% during the 1st quarter. Smartleaf Asset Management LLC now owns 529 shares of the company's stock worth $171,000 after buying an additional 182 shares during the period. Allstate Corp increased its stake in Molina Healthcare by 41.1% during the 1st quarter. Allstate Corp now owns 2,408 shares of the company's stock worth $793,000 after buying an additional 701 shares during the period. Compound Planning Inc. purchased a new stake in Molina Healthcare during the 1st quarter worth $222,000. Finally, Norinchukin Bank The increased its stake in Molina Healthcare by 14.2% during the 1st quarter. Norinchukin Bank The now owns 3,159 shares of the company's stock worth $1,041,000 after buying an additional 392 shares during the period. Hedge funds and other institutional investors own 98.50% of the company's stock.
Insider Activity at Molina Healthcare
In other news, Director Ronna Romney sold 700 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the transaction, the director directly owned 17,131 shares of the company's stock, valued at $2,633,719.94. This trade represents a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO James Woys acquired 10,000 shares of the stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the transaction, the chief operating officer directly owned 74,331 shares of the company's stock, valued at $11,591,176.14. This represents a 15.54% increase in their position. The disclosure for this purchase can be found here. Company insiders own 1.10% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Mizuho dropped their price target on shares of Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating on the stock in a research note on Friday, July 11th. Robert W. Baird dropped their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Cantor Fitzgerald reissued a "neutral" rating and set a $210.00 price objective on shares of Molina Healthcare in a report on Tuesday. Barclays decreased their price objective on shares of Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating for the company in a report on Friday, July 25th. Finally, Wells Fargo & Company decreased their price objective on shares of Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating for the company in a report on Friday, August 15th. Three equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. According to MarketBeat.com, Molina Healthcare currently has a consensus rating of "Hold" and a consensus target price of $242.91.
Read Our Latest Research Report on MOH
Molina Healthcare Price Performance
Shares of NYSE MOH traded down $1.32 during midday trading on Thursday, reaching $174.80. The company's stock had a trading volume of 1,238,821 shares, compared to its average volume of 1,006,892. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. The company has a 50 day moving average price of $203.99 and a 200 day moving average price of $274.59. Molina Healthcare, Inc has a one year low of $151.95 and a one year high of $365.23. The company has a market cap of $9.47 billion, a price-to-earnings ratio of 8.61 and a beta of 0.52.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The business had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm's revenue for the quarter was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.86 earnings per share. On average, equities research analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.